Tirzepatide may play a role in weight management in adults with T1D and obesity, even at low doses,” Jennifer R. Snaith, MD, ...
ScreenPoint Medical today announced that its Transpara ® breast imaging AI solution has been selected as the technology of ...
The AI screening trial will aim to recruit participants from seven academic medical centers, including Boston Medical Center.
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of an article titled "Melatonin agonist ...
Osaka Metropolitan University researchers developed an AR 3D food model to teach portion size estimation and conducted an ...
Based on the results of a previous research study, patients with a specific genotype may experience a reduction in future ...
Aclarion is betting that its Nociscan technology can reshape how spine surgeons identify pain-generating discs. The company’s pivotal Clarity trial is designed to provide the evidence to make that ...
AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that the first European participants have been randomized in ...
The announcement follows the release in July of topline data from OKYO’s randomized, double-masked, placebo-controlled Phase 2 proof-of-concept trial of urcosimod in 17 NCP patients conducted at Tufts ...
A nonbiologic oral IL-23 inhibitor is more effective and safer than an approved oral JAK inhibitor for moderate-to-severe ...
The theory behind leucovorin's use for autism postulates that some children have a blockage in the transport of folic acid ...
The University of Bedfordshire has partnered with community pharmacists across Bedfordshire, Luton, and Milton Keynes (BLMK) to launch a ground-breaking research project exploring new ways to support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback